GTN
MCID: GST059
MIFTS: 35

Gestational Trophoblastic Tumor (GTN)

Categories: Cancer diseases, Rare diseases, Reproductive diseases

Aliases & Classifications for Gestational Trophoblastic Tumor

MalaCards integrated aliases for Gestational Trophoblastic Tumor:

Name: Gestational Trophoblastic Tumor 53 55
Gestational Trophoblastic Disease 53 73
Gestational Trophoblastic Neoplasms 73
Gestational Trophoblastic Neoplasm 53
Gtn 53

Classifications:



External Ids:

Summaries for Gestational Trophoblastic Tumor

NIH Rare Diseases : 53 The following summary is from Orphanet, a European reference portal for information on rare diseases and orphan drugs.Orpha Number: 59305Disease definitionGestational trophoblastic tumors (GTT) are malignant forms of gestational trophoblastic disease. The tumor always follows pregnancy, most often molar pregnancy (hydatidiform mole; see this term). Four histological subtypes have been described: invasive mole, gestational choriocarcinoma, placental site trophoblastic tumor and epithelioid trophoblastic tumor (see these terms).EpidemiologyExact annual incidence is not known but it is estimated to be about 1/1,000,000 women.Clinical descriptionGTTs occur following hydatidiform moles (see this term) (15% of complete moles and about 3% of partial moles), following spontaneous miscarriage (1/150) or childbirth (1/40,000). Indicative signs are an absence of normalization or a secondary elevation of total serum chorionic gonadotropin (hCG) levels after evacuation of a hydatidiform mole (more than 60% of cases), persistent unexplained metrorrhagia following spontaneous miscarriage or voluntary termination of pregnancy (VTP) (about 30% of cases) and very occasionally, unexplained metrorrhagia in the weeks or months following normal childbirth or ectopic pregnancy (about 10% of cases). Exceptionally, metastasis may be a sign of the disease in women of childbearing age.EtiologyThe etiology of gestational trophoblastic tumors is not known. Identification of a GTT is based on a total serum hCG assay, which is recommended following hydatidiform moles in patients with metrorrhagia persisting for more than six weeks after pregnancy, and in any patient of childbearing age who has metastasis (lung, liver, brain, kidney, vagina) with no known primary tumor.Diagnostic methodsDiagnosis of a post-molar GTT relies on one of the following four criteria: stable hCG levels (variation of less than 10%) with at least four weekly assays over a period of at least three weeks (days 1, 7, 14, 21), increase of at least 10% in hCG with at least three weekly assays over at least two weeks (days 1, 7, 14), persistence of detectable hCG values for more than six months following mole evacuation or based on histological diagnosis of a choriocarcinoma.Differential diagnosisGTTs must not be confused with hydatidiform moles (see this term) and, for choriocarcinomas, with non-gestational choriocarcinomas, which are most often ovarian.Management and treatmentAs soon as the diagnosis is made, staging must be performed to identify frequent metastases. Staging involves endovaginal pelvic color doppler ultrasound, pelvic and cerebral MRI, and abdominal/chest CT. A lung X-ray must be performed to calculate the FIGO 2000 score (International Federation of Obstetrics and Gynecology) in case of lung metastasis on CT. This score makes it possible to distinguish between low-risk GTTs (score of 6 or lower) and high-risk GTTs (score of 7 or higher). Management should be multidisciplinary and must be discussed by a panel of physicians in a specialized center. Low-risk tumors are treated by systemic single-agent chemotherapy, e.g. methotrexate (marketing authorization). High-risk tumors are treated first line with systemic multi-agent chemotherapy. Hysterectomy can of course not be considered for first-line treatment in women who wish to become pregnant, unless there is no option. Placental site trophoblastic tumors and epithelioid trophoblastic tumors are special cases: the FIGO score is not appropriate and total hysterectomy is the standard treatment as these tumors are usually chemo-resistant.PrognosisThe overall recovery rate is around 99%. The prognosis is very closely related to the rapidity of diagnosis, the risk level of the tumor (low or high) and the suitability of treatment.Visit the Orphanet disease page for more resources.

MalaCards based summary : Gestational Trophoblastic Tumor, also known as gestational trophoblastic disease, is related to recurrent hydatidiform mole and pulmonary arterio-veinous fistula. An important gene associated with Gestational Trophoblastic Tumor is CGB5 (Chorionic Gonadotropin Subunit Beta 5). The drugs Nitroglycerin and Levoleucovorin have been mentioned in the context of this disorder. Affiliated tissues include bone, liver and brain.

Related Diseases for Gestational Trophoblastic Tumor

Graphical network of the top 20 diseases related to Gestational Trophoblastic Tumor:



Diseases related to Gestational Trophoblastic Tumor

Symptoms & Phenotypes for Gestational Trophoblastic Tumor

Drugs & Therapeutics for Gestational Trophoblastic Tumor

Drugs for Gestational Trophoblastic Tumor (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 171)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Nitroglycerin Approved, Investigational Phase 4,Phase 2 55-63-0 4510
2
Levoleucovorin Approved, Investigational Phase 2, Phase 3,Phase 3 68538-85-2
3
leucovorin Approved Phase 2, Phase 3,Phase 3 58-05-9 6006 143
4
Methotrexate Approved Phase 2, Phase 3,Phase 3 59-05-2, 1959-05-2 126941
5
Dactinomycin Approved, Investigational Phase 3,Phase 2 50-76-0 457193 2019
6
Amifostine Approved, Investigational Phase 3 20537-88-6 2141
7
Caspofungin Approved Phase 3,Phase 2 179463-17-3, 162808-62-0 468682 2826718
8
Amphotericin B Approved, Investigational Phase 3 1397-89-3 5280965 14956
9
Miconazole Approved, Investigational, Vet_approved Phase 3,Phase 2,Not Applicable 22916-47-8 4189
10
Cyclophosphamide Approved, Investigational Phase 3,Not Applicable 6055-19-2, 50-18-0 2907
11
Captopril Approved Phase 3 62571-86-2 44093
12
Ribavirin Approved Phase 3 36791-04-5 37542
13
Palivizumab Approved, Investigational Phase 3 188039-54-5
14
Fluconazole Approved, Investigational Phase 3 86386-73-4 3365
15
Itraconazole Approved, Investigational Phase 3,Not Applicable 84625-61-6 55283
16
Acyclovir Approved Phase 3 59277-89-3 2022
17
Carboplatin Approved Phase 3,Phase 1 41575-94-4 10339178 38904 498142
18
Etoposide Approved Phase 3,Phase 1 33419-42-0 36462
19
Vincristine Approved, Investigational Phase 3 57-22-7, 2068-78-2 5978
20
Paclitaxel Approved, Vet_approved Phase 3 33069-62-4 36314
21
Cisplatin Approved Phase 3 15663-27-1 2767 441203 84093
22
Estradiol Approved, Investigational, Vet_approved Phase 3 50-28-2 5757
23
Moxifloxacin Approved, Investigational Phase 3 354812-41-2, 151096-09-2 152946
24 Estradiol valerate Approved, Investigational, Vet_approved Phase 3 979-32-8
25
Polyestradiol phosphate Approved Phase 3 28014-46-2
26
Norgestimate Approved, Investigational Phase 3 35189-28-7 6540478
27
Ethinyl Estradiol Approved Phase 3 57-63-6 5991
28
Mycophenolic acid Approved Phase 3 24280-93-1 446541
29
Folic Acid Approved, Nutraceutical, Vet_approved Phase 2, Phase 3,Phase 3 59-30-3 6037
30 Bone Density Conservation Agents Phase 2, Phase 3,Phase 3
31 Micronutrients Phase 2, Phase 3,Phase 3
32 Immunosuppressive Agents Phase 2, Phase 3,Phase 3,Phase 1,Not Applicable
33 Immunologic Factors Phase 2, Phase 3,Phase 3,Phase 1,Not Applicable
34 Vitamin B9 Phase 2, Phase 3,Phase 3
35 Vitamins Phase 2, Phase 3,Phase 3
36 Dermatologic Agents Phase 2, Phase 3,Phase 3,Not Applicable
37 Antimetabolites, Antineoplastic Phase 2, Phase 3,Phase 3
38 Vitamin B Complex Phase 2, Phase 3,Phase 3
39 Antirheumatic Agents Phase 2, Phase 3,Phase 3,Not Applicable
40 Liver Extracts Phase 2, Phase 3,Phase 3,Phase 1
41 Folic Acid Antagonists Phase 2, Phase 3,Phase 3
42 Antimetabolites Phase 2, Phase 3,Phase 3
43 Hematinics Phase 2, Phase 3,Phase 3
44 Folate Phase 2, Phase 3,Phase 3
45 Trace Elements Phase 2, Phase 3,Phase 3
46 Protective Agents Phase 2, Phase 3,Phase 3,Not Applicable
47 Nucleic Acid Synthesis Inhibitors Phase 2, Phase 3,Phase 3
48 Calcium, Dietary Phase 2, Phase 3,Phase 3,Not Applicable
49 Antidotes Phase 2, Phase 3,Phase 3,Not Applicable
50 Anti-Bacterial Agents Phase 3,Phase 2,Phase 1,Not Applicable

Interventional clinical trials:

(show top 50) (show all 76)
# Name Status NCT ID Phase Drugs
1 A Comparison of Single Versus Double Evacuation for Treatment of Hydatidiform Mole Recruiting NCT01630954 Phase 4
2 Surgery Plus Single Agent Chemotherapy Versus Primary Chemotherapy for Gestational Trophoblastic Neoplasms Unknown status NCT02606539 Phase 2, Phase 3 Methotrexate plus folinic acid alone
3 Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia Completed NCT00003702 Phase 3 Methotrexate
4 RCT on the Efficacy of Methotrexate for the Prevention of GTD Completed NCT01984099 Phase 3 Methotrexate;Vitamin B Complex
5 Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer Completed NCT00058071 Phase 3 amifostine trihydrate
6 Music Therapy or Book Discussion in Improving Quality of Life in Young Patients Undergoing Stem Cell Transplant Completed NCT00305851 Phase 3
7 Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment Completed NCT00008359 Phase 3 caspofungin acetate;liposomal amphotericin B
8 Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation Completed NCT00004230 Phase 3 captopril;cyclophosphamide
9 Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Completed NCT00003938 Phase 3 liposomal amphotericin B
10 Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation Completed NCT00014391 Phase 3 ribavirin
11 Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation Completed NCT00003883 Phase 3 fluconazole;itraconazole
12 Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation Completed NCT00045292 Phase 3 acyclovir;acyclovir sodium;valacyclovir
13 Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor Recruiting NCT02639650 Phase 3 Etoposide;actinomycin D;methotrexate;vincristine;cyclophosphamide;Paclitaxel;Cisplatin;Carboplatin
14 Methotrexate Single-dose Treatment and Methotrexate/Actinomycin-D Single-dose Treatment in Low-Risk Gestational Trophoblastic Neoplasia Active, not recruiting NCT01823315 Phase 3 MTX 1;MTX 2
15 Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia Active, not recruiting NCT01535053 Phase 3 Leucovorin Calcium;Methotrexate
16 Study of Hysteroscopic Repeat Curettage as the First-line Treatment in Low-risk Postmolar Gestational Trophoblastic Neoplasia Not yet recruiting NCT03703271 Phase 3 Methotrexate
17 Rescue Regimen and High Dose Methotrexate in Management of Presistent Gestational Trophoplastic Neoplasia Not yet recruiting NCT03280979 Phase 2, Phase 3 rescue regimen;high dose methotrxate
18 Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant Terminated NCT00324324 Phase 3 moxifloxacin hydrochloride;Placebo
19 Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD) Terminated NCT00089141 Phase 3 mycophenolate mofetil;placebo
20 Dactinomycin in Treating Patients With Persistent or Recurrent Gestational Trophoblastic Neoplasia Completed NCT00003688 Phase 2
21 A Trial for Patients With Gestational Trophoblastic Disease Completed NCT00190918 Phase 2 Pemetrexed
22 Second Curettage in Treating Patients With Persistent Non-metastatic Gestational Trophoblastic Tumors Completed NCT00521118 Phase 2
23 Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant Completed NCT00410657 Phase 2 methylprednisolone;prednisone
24 Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors Completed NCT00004157 Phase 2
25 Campath-1H + FK506 and Methylprednisolone for GVHD Completed NCT00109993 Phase 2 methylprednisolone;tacrolimus
26 Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation Completed NCT00003887 Phase 2
27 Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon Completed NCT00010283 Phase 1, Phase 2 beclomethasone dipropionate
28 Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation Completed NCT00064311 Phase 1, Phase 2 ravuconazole
29 Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer Completed NCT00003408 Phase 2
30 Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer Completed NCT01764802 Phase 2
31 Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant Completed NCT00795769 Phase 2 ondansetron
32 Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant Completed NCT00110045 Phase 2 caspofungin acetate
33 Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell Transplant Completed NCT00357084 Phase 2 methotrexate;methylprednisolone;prednisone
34 Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation Completed NCT00002673 Phase 2
35 Avelumab in Chemo-resistant Gestational Trophoblastic Neoplasias Recruiting NCT03135769 Phase 2 Avelumab administration at 10mg/kg
36 Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Recruiting NCT02834013 Phase 2
37 Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Low-Risk Gestational Trophoblastic Tumor After a Molar Pregnancy Terminated NCT00096187 Phase 2 pemetrexed disodium
38 Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN) Terminated NCT02664961 Phase 2 TRC105;Bevacizumab
39 Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload Terminated NCT01159067 Phase 2 deferasirox
40 Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions Unknown status NCT00066404 Phase 1
41 Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections Unknown status NCT00769613 Phase 1
42 Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors Completed NCT00003107 Phase 1
43 Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia Completed NCT01484015 Phase 1 cefepime hydrochloride
44 Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity Completed NCT00003548 Phase 1 aminocamptothecin colloidal dispersion
45 Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors Completed NCT00003597 Phase 1 carboplatin;etoposide;ifosfamide
46 Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant Completed NCT00569283 Phase 1
47 Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy Completed NCT00509691 Phase 1
48 Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant Completed NCT00361049 Phase 1
49 Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803 Recruiting NCT02890758 Phase 1
50 Detection of Human Chorionic Gonadotropin by Interferometry in Gestational Trophoblastic Disease Unknown status NCT00166790 chemotherapy agents

Search NIH Clinical Center for Gestational Trophoblastic Tumor

Genetic Tests for Gestational Trophoblastic Tumor

Anatomical Context for Gestational Trophoblastic Tumor

MalaCards organs/tissues related to Gestational Trophoblastic Tumor:

41
Bone, Liver, Brain, Bone Marrow, Lung, Kidney, Placenta

Publications for Gestational Trophoblastic Tumor

Articles related to Gestational Trophoblastic Tumor:

(show top 50) (show all 672)
# Title Authors Year
1
Pulmonary Arteriovenous Malformation After Metastatic Gestational Trophoblastic Tumor. ( 29884426 )
2018
2
Multiple metastatic gestational trophoblastic disease after a twin pregnancy with complete hydatidiform mole and coexisting fetus, following assisted reproductive technology: Case report and literature review. ( 30122584 )
2018
3
SEOM clinical guidelines in gestational trophoblastic disease (2017). ( 29149431 )
2018
4
Systematic review of health-related quality of life and patient-reported outcome measures in gestational trophoblastic disease: a parallel synthesis approach. ( 29304364 )
2018
5
Gestational Trophoblastic Disease Electronic Consults: What Do Patients and Physicians Want to Know? ( 29324544 )
2018
6
Identification of microRNA signature in the progression of gestational trophoblastic disease. ( 29367697 )
2018
7
Update on the pathology of gestational trophoblastic disease. ( 30129126 )
2018
8
Advanced gestational trophoblastic disease: A case report of medical management prior to surgical intervention. ( 30167379 )
2018
9
Experience With the Use of an Online Community on Facebook for Brazilian Patients With Gestational Trophoblastic Disease: Netnography Study. ( 30249575 )
2018
10
Update on the diagnosis and management of gestational trophoblastic disease. ( 30306586 )
2018
11
False diagnosis of and needless therapy for presumed gestational trophoblastic disease in women with an unusual site of residual pregnancy. ( 30409101 )
2018
12
15years of progress in gestational trophoblastic disease: Scoring, standardization, and salvage. ( 27743739 )
2017
13
Comparing and evaluating the efficacy of methotrexate and actinomycin D as first-line single chemotherapy agents in low risk gestational trophoblastic disease. ( 27819410 )
2017
14
Qualitative and quantitative analysis of diffusion-weighted imaging of gestational trophoblastic disease: Can it predict progression of molar pregnancy to persistent form of disease? ( 28189211 )
2017
15
Gestational Trophoblastic Disease: Clinical and Imaging Features. ( 28287945 )
2017
16
Follow-up of gestational trophoblastic disease/neoplasia via quantification of circulating nucleic acids of placental origin using C19MC microRNAs, hypermethylated RASSF1A, and SRY sequences. ( 28381180 )
2017
17
Pathogenic variant in NLRP7 (19q13.42) associated with recurrent gestational trophoblastic disease: Data from early embryo development observed during in vitro fertilization. ( 28428943 )
2017
18
The role of surgery in the management of women with gestational trophoblastic disease. ( 28489216 )
2017
19
Implementation and Monitoring of a Gestational Trophoblastic Disease Management Program in a Tertiary Hospital in Morocco: Opportunities and Challenges. ( 28567058 )
2017
20
Obstetric ultrasound aids prompt referral of gestational trophoblastic disease in marginalized populations on the Thailand-Myanmar border. ( 28571514 )
2017
21
Comparison of 2 Human Chorionic Gonadotropin Immunoassays Commercially Available for Monitoring Patients With Gestational Trophoblastic Disease. ( 28692637 )
2017
22
Gestational Trophoblastic Disease - Clinicopathological Study at Tertiary Care Hospital. ( 28969138 )
2017
23
Gestational Trophoblastic Disease. ( 29101942 )
2017
24
Gestational trophoblastic disease in Campinas, Brazil and persistency predictors. ( 29767872 )
2017
25
Primary Gestational Trophoblastic Disease of the Fallopian Tube: A Case Series Analysis and Literature Review. ( 30230306 )
2017
26
Placental Site Trophoblastic Tumor: A Distinct Entity of Gestational Trophoblastic Disease Experience from a Tertiary Referral Center in Hong Kong. ( 30408381 )
2016
27
Trends in incidence for gestational trophoblastic disease over the last 20 years in a population-based study. ( 26586414 )
2016
28
Gestational and Non-gestational Trophoblastic Disease. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry No. 032/049, December 2015). ( 26941444 )
2016
29
Management of gestational trophoblastic disease: a survey of New Zealand O&G practice. ( 27005872 )
2016
30
Conservative Chemotherapy in Gestational Trophoblastic Disease: Experience With Etoposide, Methotrexate, and Dactinomycin Chemotherapy. ( 27057813 )
2016
31
Mental Representations of Illness in Patients with Gestational Trophoblastic Disease: How Do Patients Perceive Their Condition? ( 27101144 )
2016
32
Gestational trophoblastic disease in a Greenlandic Inuit: diagnosis and treatment in a remote area. ( 27154987 )
2016
33
Gestational Trophoblastic Disease: Opportunities for a National Registry Collaboration. ( 27258726 )
2016
34
A 10-Year Clinical Experience of Gestational Trophoblastic Disease at Rajavithi Hospital, 2001-2010. ( 27266212 )
2016
35
Gestational Trophoblastic Disease: Presentations from the XVIIIth World Congress on Gestational Trophoblastic Diseases. ( 27424355 )
2016
36
Centralized Coordination of Decentralized Assistance for Patients with Gestational Trophoblastic Disease in Brazil: A Viable Strategy for Developing Countries. ( 27424363 )
2016
37
Clinical and radiological correlations in patients with gestational trophoblastic disease. ( 27777478 )
2016
38
Gestational Trophoblastic Disease and Choriocarcinoma. ( 26366695 )
2015
39
An investigative study into psychological and fertility sequelae of gestational trophoblastic disease: the impact on patients' perceived fertility, anxiety and depression. ( 26030770 )
2015
40
BEP for high-risk gestational trophoblastic tumor: results from a cohort of 45 patients. ( 26775361 )
2015
41
A rare case of bilateral ectopic pregnancy and differential diagnosis of gestational trophoblastic disease. ( 25717436 )
2015
42
FBI-1 Is Overexpressed in Gestational Trophoblastic Disease and Promotes Tumor Growth and Cell Aggressiveness of Choriocarcinoma via PI3K/Akt Signaling. ( 26093985 )
2015
43
Update on the diagnosis and management of gestational trophoblastic disease. ( 26433668 )
2015
44
Characterization of apoptosis and autophagy through Bcl-2 and Beclin-1 immunoexpression in gestational trophoblastic disease. ( 26494988 )
2015
45
Is Doppler ultrasound useful for evaluating gestational trophoblastic disease? ( 26735221 )
2015
46
Investigation of Risk Factors, Stage and Outcome in Patients with Gestational Trophoblastic Disease since 2001 to 2011 in Iran-Yazd. ( 26759532 )
2015
47
Thyroid storm-induced multi-organ failure in the setting of gestational trophoblastic disease. ( 25315998 )
2015
48
Human placental growth hormone: a potential new biomarker in gestational trophoblastic disease. ( 25448485 )
2015
49
Atypical placental site nodule (APSN) and association with malignant gestational trophoblastic disease; a clinicopathologic study of 21 cases. ( 25675185 )
2015
50
Quantitative urine hCG and urine pregnancy test in gestational trophoblastic disease patients with low hCG titer. ( 25764611 )
2015

Variations for Gestational Trophoblastic Tumor

Expression for Gestational Trophoblastic Tumor

Search GEO for disease gene expression data for Gestational Trophoblastic Tumor.

Pathways for Gestational Trophoblastic Tumor

GO Terms for Gestational Trophoblastic Tumor

Sources for Gestational Trophoblastic Tumor

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....